Senti BiosciencesSNTI
13F holders, Q1 2026 (March 31)16holders +1
4new positions
4sold out
$0.81avg. 13F price*
At the end of Q1 2026, 16 institutions reported holding Senti Biosciences Inc. (SNTI) in their 13F filings, up 1 from Q4 2025. 4 opened new positions and 4 sold out. The largest holders were NEA Management Company, LLC ($3.1M), Nantahala Capital Management, LLC ($721K) and Vanguard Capital Management LLC ($436K).
- Company
- Senti Biosciences Inc.
- CUSIP
- 81726A209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $36K |
| Exits | 4 | $90K |
All 13F filers, Q4 2025 → Q1 2026: 112,166 shares bought and 86,324 shares sold, net +25,842 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 16 holders
| NEA Management Company, LLC | 0.17% | No change | 3,775,615 | $3.1M |
| Nantahala Capital Management, LLC | 0.05% | No change | 888,000 | $721K |
| Vanguard Capital Management LLC | 0.00% | — | 537,504 | $436K |
| Geode Capital Management, LLC | 0.00% | Add +43.0% | 207,043 | $168K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 91,193 | $74K |
| Menlo Ventures Management, L.P. | 0.01% | — | 35,737 | $29K |
| BlackRock, Inc. | 0.00% | Add +7.2% | 25,074 | $20K |
| XTX Topco Ltd | 0.00% | New | 17,277 | $14K |
| Northern Trust Corp. | 0.00% | No change | 16,778 | $14K |
| HRT Financial LP | 0.00% | New | 14,844 | $12K |
| NewEdge Advisors, LLC | 0.00% | New | 12,000 | $10K |
| State Street Corp. | 0.00% | No change | 10,010 | $8K |
| UBS Group AG | 0.00% | Add +90.7% | 8,637 | $7K |
| SBI Securities Co., Ltd. | 0.00% | Reduce -0.6% | 334 | $271 |
| Morgan Stanley | 0.00% | No change | 160 | $130 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 1 | $1 |
"% of holder's portfolio" is SNTI's weight in each manager's 13F, not the share of Senti Biosciences Inc. the manager owns.